3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Completed
7
Unknown
2
Active not recruiting
2
Suspended
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Breast
1
Conditions
Breast Neoplasms
11
Prostatic Neoplasms
4
Colorectal Neoplasms
4
Neoplasm Metastasis
3
Lymphoma
3
Lung Neoplasms
3
Uterine Cervical Neoplasms
2
Papillomavirus Infections
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Obesity-Related Malignant Neoplasm
2
Motor Activity
2
Hematologic Neoplasms
2
Ventricular Dysfunction, Left
1
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Smoking Cessation
1
Skin Carcinoma
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
No Evidence of Disease
1
New Healthcare Approach
1
Multiple Myeloma
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Kidney Neoplasms
1
Inflammatory Breast Neoplasms
1
Hodgkin Disease
1
Interventions
Exercise
22
Surveys and Questionnaires
3
Resistance Training
3
Diet
3
Control Groups
3
Nutrition Assessment
2
Methods
2
Interviews as Topic
2
High-Intensity Interval Training
2
Exercise Therapy
2
Counseling
2
pertuzumab
1
pembrolizumab
1
cytisine
1
cemiplimab
1
avelumab
1
Weights and Measures
1
Trastuzumab
1
Therapeutics
1
Telemedicine
1
Standard of Care
1
Spirometry
1
Rehabilitation
1
Psychiatric Rehabilitation
1
Palliative Care
1
Paclitaxel
1
Nivolumab
1
Neoadjuvant Therapy
1
Ipilimumab
1
Immune Checkpoint Inhibitors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Active not recruiting
×
Motor Activity
×
Methods
×
Clear all
NCT01621659
2026-05-11
TITAN
University of Alberta
Phase 2
Active not recruiting
80 enrolled
NCT06396611
2025-03-19
ADRENALINE
Universidade do Porto
Phase NA
Active not recruiting
11 enrolled